At this time, posts about Genexine are rapidly increasing on portals and stock communities, while foreign investors are tentatively estimated to have net sold 5,000 shares today. Genexine is known as a specialized company in biopharmaceutical development.

As of 11:30 AM on the 19th, Genexine's stock price is 68,500 KRW, down 1.44% from the previous day, with a trading volume of 249,278 shares, which is about 34.58% of the 5-day average trading volume. On May 14, Genexine was a market issue with the headline "Institutions 'selling' causing a downward trend."

In addition to Genexine, posts by investors are also rapidly increasing for Theragen Etex (066700), KPS (256940), and Jaan (221610).

※Source: AI Investment Assistant AI Rassiro

※ This article was generated in real-time by an article auto-generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.




This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing